CD4 and myeloid sarcoma: Most importantly, αvβ3 integrin is upregulated on ex vivo CD4 T lymphocytes from untreated relapsing-remitting (RR) MS subjects and to a lesser extent from treated RRMS subjects, compared to healthy controls (Fig. 2d).